{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:07:33Z","timestamp":1790420853380,"version":"4.1.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11940-018-0508-3","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T01:14:06Z","timestamp":1528161246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic Symptomatic Strategies in the Parasomnias"],"prefix":"10.1007","volume":"20","author":[{"given":"Raffaele","family":"Manni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Terzaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"508_CR1","unstructured":"American Academy of Sleep Medicine, International classification of sleep disorders, rd ed. Darien, IL, 2014."},{"issue":"11","key":"508_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0164769","volume":"11","author":"H Stallman","year":"2016","unstructured":"Stallman H, Kohler M. Prevalence of sleepwalking: a systematic review and meta-analysis. PlosOne. 2016;11(11):10.","journal-title":"PlosOne"},{"issue":"12","key":"508_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/sleep\/32.12.1637","volume":"32","author":"C Derry","year":"2009","unstructured":"Derry C, Harvey A, Walker M, Duncan J, Berkovic S. NREM arousal parasomnias and their distinction from nocturnal frontal lobe epilepsy: a video EEG Analysis. Sleep. 2009;32(12):1637\u201344.","journal-title":"Sleep"},{"issue":"3819","key":"508_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1126\/science.159.3819.1070","volume":"159","author":"J Broughton","year":"1968","unstructured":"Broughton J. Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares occur in confusional states of arousal, not in \u201cdreaming sleep\u201d. Science. 1968;159(3819):8.","journal-title":"Science"},{"key":"508_CR5","doi-asserted-by":"crossref","unstructured":"Nir Y, Staba R, Andrillon T, Vyazovskiy V, Cirelli C, Fried I, et al. Regional slow waves and spindles in human sleep. Neuron. 2011;70:153\u201369.","DOI":"10.1016\/j.neuron.2011.02.043"},{"key":"508_CR6","doi-asserted-by":"crossref","unstructured":"Januszko P, Niemcewicz S, Gajda T, Wolynczyk-Gmaj D, Piotrowska A, Gmaj B, et al. Sleepwalking episodes are preceded by arousal-related activation in the cingulate motor area: EEG current density imagine. Clin Neurophysion. 2016;127:530\u20136.","DOI":"10.1016\/j.clinph.2015.01.014"},{"key":"508_CR7","doi-asserted-by":"crossref","unstructured":"Terzaghi M, Sartori I, Tassi G, Didato G, Rustioni V, LoRusso G, et al. Evidence of dissociated arousal states during NREM parasomnia from an intracerebral neurophysiological study. Sleep. 2009;32:409\u201312.","DOI":"10.1093\/sleep\/32.3.409"},{"key":"508_CR8","doi-asserted-by":"crossref","unstructured":"Gibbs S, Proserpio P, Terzaghi M, Pigorini A, Sarasso S, Lo Russo G, et al. Sleep-related epileptic behaviors and non-REM-related parasomnias: insights from stereo-EEG. Sleep Med Rev. 2016;25:4\u201320.","DOI":"10.1016\/j.smrv.2015.05.002"},{"key":"508_CR9","doi-asserted-by":"crossref","unstructured":"Terzaghi M, Sartori I, Tassi L, Rustioni V, Proserpio P, Lorusso G, et al. Dissociated local arousal states underlying essential cliical features of non-rapid eye movement arousal parasomnia: an intracerebral stero-electroencephalographic study. J Sleep Res. 2012;21(5):502\u20136.","DOI":"10.1111\/j.1365-2869.2012.01003.x"},{"key":"508_CR10","first-page":"2012","volume":"312693","author":"P Halasz","year":"2012","unstructured":"Halasz P, Kelemen A, Sz\u00fccs A. Physiopathogenetic interrelationship between nocturnal frontal lobe epilepsy and NREM arousal parasomnias. Epilepsy Res Treat. 2012;312693:2012.","journal-title":"Epilepsy Res Treat"},{"key":"508_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.sleep.2015.05.006","volume":"16","author":"M Terzaghi","year":"2015","unstructured":"Terzaghi M, Manni R. Mapping the features of arousal parasomnias in adults: on the way to better undersand arousal parasomnias and ease differential diagnosis. Sleep Med. 2015;16:1439\u201340.","journal-title":"Sleep Med"},{"key":"508_CR12","doi-asserted-by":"crossref","unstructured":"Siclari F, Khatami R, Urbanlok F, Nobili L, Mahowald MW, Schenck CH, et al. Violence in sleep. Brain. 2010;33(Pt 12):3494\u2013509.","DOI":"10.1093\/brain\/awq296"},{"issue":"3","key":"508_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5665\/sleep.2446","volume":"36","author":"R Lopez","year":"2013","unstructured":"Lopez R, Jaussent I, Scholz S, Bayard S, Montplaisir J, Dauvilliers Y. Functional impairment in adult sleepwalkers: a case-control study. Sleep. 2013;36(3):345\u201351.","journal-title":"Sleep"},{"issue":"4","key":"508_CR14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ncl.2010.03.025","volume":"8","author":"H Attarian","year":"2010","unstructured":"Attarian H. Treatment options for parasomnias. Neurol Clin. 2010;8(4):1089\u2013106.","journal-title":"Neurol Clin"},{"key":"508_CR15","doi-asserted-by":"crossref","unstructured":"Howell MJ. Parasomnias: an updated review. Neurotherapeutics. 2012;9(4)","DOI":"10.1007\/s13311-012-0143-8"},{"issue":"s7","key":"508_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1528-1167.2012.03710.x","volume":"53","author":"P Tinuper","year":"2012","unstructured":"Tinuper P, Bisulli F, Provini F. The parasomnias: mechanisms and treatment. Epilepsia. 2012;53(s7):12\u20139.","journal-title":"Epilepsia"},{"issue":"1","key":"508_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.smrv.2006.06.003","volume":"11","author":"M Pressman","year":"2007","unstructured":"Pressman M. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev. 2007;11(1):5\u201330.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"508_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11940-012-0199-0","volume":"14","author":"S Kotagal","year":"2012","unstructured":"Kotagal S. Treatment of dyssomnias and parasomnias in childhood. Curr Treat Options Neurol. 2012;14(6):630\u201349.","journal-title":"Curr Treat Options Neurol"},{"key":"508_CR19","doi-asserted-by":"crossref","unstructured":"Galbiati A, Rinaldi F, Giora E, Ferini-Strambi L, Marelli S. Behavioural and cognitive-behavioural treatments of parasomnias. Behav Neurol. pp. Article ID 786928, 8 pages, 2015. This is an updated review of non pharmachological therapeutic options in NREM and REM and other rare parasomnias.","DOI":"10.1155\/2015\/786928"},{"issue":"Pt 5","key":"508_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/brain\/awh481","volume":"128","author":"C Guilleminault","year":"2005","unstructured":"Guilleminault C, Kirisoglu C, Bao G, Arias V, Chan A, Li K. Adult chronic sleepwalking and its treatment based on polysomnography. Brain. 2005;128(Pt 5):1062\u20139.","journal-title":"Brain"},{"issue":"2","key":"508_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11940-015-0388-8","volume":"18","author":"V Cochen De Cock","year":"2016","unstructured":"Cochen De Cock V. Sleepwalking. Curr Treat Options Neurol. 2016;18(2):6.","journal-title":"Curr Treat Options Neurol"},{"issue":"9","key":"508_CR22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1176\/ajp.146.9.1166","volume":"146","author":"C Schenck","year":"1989","unstructured":"Schenck C, Milner D, Hurwitz T, Bundlie S, Mahowald M. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry. 1989;146(9):1166\u201373.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"508_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0002-9343(97)89493-4","volume":"100","author":"C Schenck","year":"1996","unstructured":"Schenck C, Mahowald M. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100(3):333\u20137.","journal-title":"Am J Med"},{"issue":"9","key":"508_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3109\/00207454.2013.783579","volume":"123","author":"H Attarian","year":"2013","unstructured":"Attarian H, Zhu L. Treatment options for disorders of arousal: a case series. Int J Neurosci. 2013;123(9):623\u20135.","journal-title":"Int J Neurosci"},{"issue":"10","key":"508_CR25","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1517\/14656566.5.10.2069","volume":"5","author":"A Remulla","year":"2004","unstructured":"Remulla A, Guilleminault C. Sonnambulism (sleepwalking). Expert Opin Pharmacother. 2004;5(10):2069\u201374.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"508_CR26","first-page":"49","volume":"6","author":"W Reid","year":"1984","unstructured":"Reid W, Haffke E, Chu C. Diazepam in intractable sleepwalking: a pilot study. Hillside J Clin Psychiatry. 1984;6(1):49\u201355.","journal-title":"Hillside J Clin Psychiatry"},{"key":"508_CR27","doi-asserted-by":"crossref","unstructured":"Berlin R, Qayyum U. Sleepwalking: diagnosis and treatment through the life cycle. 1986;27(11):755\u201360.","DOI":"10.1016\/S0033-3182(86)72602-9"},{"issue":"5","key":"508_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1212\/WNL.40.5.749","volume":"40","author":"N Kavey","year":"1990","unstructured":"Kavey N, Whyte J, Restor SJ, Gidro-Frank S. Sonnambulism in adults. Neurology. 1990;40(5):749\u201352.","journal-title":"Neurology"},{"issue":"5","key":"508_CR29","first-page":"209","volume":"48","author":"A Cooper","year":"1987","unstructured":"Cooper A. Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam. J Clin Psychiatry. 1987;48(5):209\u201310.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"508_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10401239409148998","volume":"6","author":"R Balon","year":"1994","unstructured":"Balon R. Sleep terror disorder and insomnia treated with trazodone: a case report. Am Clin Psychiatry. 1994;6(3):161\u20133.","journal-title":"Am Clin Psychiatry"},{"issue":"9072","key":"508_CR31","first-page":"185","volume":"350","author":"S Wilson","year":"1997","unstructured":"Wilson S, Lillywhite A, Potokar JP, Bell C, Nutt D. Adult night terrors and paroxetine. Lancet. 1997;350(9072):185.","journal-title":"Lancet"},{"issue":"3","key":"508_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/136515001317021707","volume":"5","author":"J Fr\u00f6lich","year":"2001","unstructured":"Fr\u00f6lich J, Wiater A, Gerd Lehmkuhl J. Successful treatment of severe parasomnias with paroxetine in a 12-year-old boy. Int J Psychiatry Clin Pract. 2001;5(3):215\u20138.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"4","key":"508_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1192\/bjp.164.4.551","volume":"164","author":"A Lillywhite","year":"1994","unstructured":"Lillywhite A, Wilson S, Nutt D. Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry. 1994;164(4):551\u20134.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"508_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4088\/JCP.v64n0420e","volume":"64","author":"T Kawashima","year":"2003","unstructured":"Kawashima T, Yamada S. Paroxetine-induced somnambulism. J Clin Psychiatry. 2003;64(4):483.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"508_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mehy.2004.06.013","volume":"64","author":"G Juszczak","year":"2005","unstructured":"Juszczak G, Swiergiel A. Serotoninergic hypothesis of sleepwalking. Med Hypotheses. 2005;64(1):28\u201332.","journal-title":"Med Hypotheses"},{"issue":"7","key":"508_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00431-004-1444-7","volume":"163","author":"O Bruni","year":"2004","unstructured":"Bruni O, Ferri R, Milano S, Verrillo E. L-5-Hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr. 2004;163(7):402\u20137.","journal-title":"Eur J Pediatr"},{"issue":"10","key":"508_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1089\/cap.2016.0088","volume":"26","author":"D Sasayama","year":"2016","unstructured":"Sasayama D, Washizuka S, Honda H. Effective treatment of night terrors and sleepwalking with ramelteon. J Child Adolesc Psychopharmacol. 2016;26(10):948.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"508_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4088\/JCP.v59n0104","volume":"59","author":"J Winkelman","year":"1998","unstructured":"Winkelman J. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry. 1998;59(1):14\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"508_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/sleep\/14.5.419","volume":"14","author":"C Schenck","year":"1991","unstructured":"Schenck C, Hurwitz T, Bundlie S, Mahowald M. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep. 1991;14(5):419\u201331.","journal-title":"Sleep"},{"issue":"7","key":"508_CR40","first-page":"69","volume":"3","author":"D Markov","year":"2006","unstructured":"Markov D, Jaffe F, Doghramji K. Update on parasomnias. Psychiatry. 2006;3(7):69\u201376.","journal-title":"Psychiatry"},{"issue":"6","key":"508_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/pcn.12263","volume":"69","author":"Y Inoue","year":"2015","unstructured":"Inoue Y. Sleep-related eating disorder and its associated conditions. Psychiatry Clin Neurosci. 2015;69(6):309\u201320.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"508_CR42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5664\/jcsm.2036","volume":"8","author":"M Howell","year":"2012","unstructured":"Howell M, Schenck C. Restless nocturnal eating: a common feature of Willis-Ekbom syndrome (RLS). J Clin Sleep Med. 2012;8(4):413\u20139.","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"508_CR43","first-page":"64","volume":"3","author":"R Auger","year":"2006","unstructured":"Auger R. Sleep-related eating disorders. Psychiatry. 2006;3(11):64\u201370.","journal-title":"Psychiatry"},{"issue":"8","key":"508_CR44","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.sleep.2012.06.012","volume":"13","author":"A Brion","year":"2012","unstructured":"Brion A, Flamand M, Oudiette D, Voillery D, Golmard J, Arnulf I. Sleep-related eating disorder versus sleepwalking: a controlled study. Sleep Med. 2012;13(8):1094\u2013101.","journal-title":"Sleep Med"},{"issue":"8","key":"508_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11940-015-0361-6","volume":"17","author":"G Chiaro","year":"2015","unstructured":"Chiaro G, Caletti M, Provini F. Treatment of sleep-related eating disorder. Curr Treat Options Neurol. 2015;17(8):361. Selective serotonin reuptake inhibitors (SSRIs) at mean dosages of 20 to 30\u00a0mg\/day are considered as first-line treatment of SRED. Topiramate at 100\u2013300\u00a0mg\/day and clonazepam at 0.5\u20132.0\u00a0mg\/day are recommended as alternative options. Treatment of comorbid sleep disorders is of primary importance in SRED related to other parasomnias or sleep disturbances.","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"508_CR46","first-page":"457","volume":"16","author":"C Schenck","year":"1993","unstructured":"Schenck C, Hurwitz T, O\u2019Connor K, Mahowald M. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep. 1993;16(5):457\u201366.","journal-title":"Sleep"},{"issue":"2","key":"508_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.sleep.2013.10.010","volume":"15","author":"J Santin","year":"2014","unstructured":"Santin J, Mery V, Elso M, Retamal E, Torres C, Ivelic J. Sleep-related eating disorder: a descriptive study in Chilean patients. Sleep Med. 2014;15(2):163\u20137.","journal-title":"Sleep Med"},{"issue":"3","key":"508_CR48","first-page":"175","volume":"18","author":"T Miyakota","year":"2003","unstructured":"Miyakota T, Yasukawa R, Tsubouchi K, Miura S, Shimizu Y, Sukegawa T. Successful treatment of nocturnal eating\/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol. 2003;18(3):175\u20137.","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"508_CR49","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.4088\/JCP.v67n1109","volume":"67","author":"J Winkelman","year":"2006","unstructured":"Winkelman J. Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case series. J Clin Psychiatry. 2006;67(11):1729\u201334.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"508_CR50","doi-asserted-by":"publisher","first-page":"E617","DOI":"10.1152\/ajpendo.00437.2004","volume":"288","author":"J Wilkes","year":"2005","unstructured":"Wilkes J, Nelson E, Osborne M, Demarest K, Olefsky J. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats. Am J Physiol Endocrinol Metab. 2005;288(3):E617\u201324.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"508_CR51","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1463-1326.2004.00403.x","volume":"7","author":"Y Liang","year":"2005","unstructured":"Liang Y, Chen X, Osborne M, DeCarlo S, Jetton T, Demarest K. Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db\/db mice. Diabetes Obes Metab. 2005;7(4):360\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"508_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1389-9457(03)00060-1","volume":"4","author":"J Winkelman","year":"2003","unstructured":"Winkelman J. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med. 2003;4(3):243\u20136.","journal-title":"Sleep Med"},{"issue":"6","key":"508_CR53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1468-1331.2005.01017.x","volume":"12","author":"F Provini","year":"2005","unstructured":"Provini F, Albani F, Vetrugno R, Vignatelli L, Lombardi C, Plazzi G. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol. 2005;12(6):432\u20136.","journal-title":"Eur J Neurol"},{"key":"508_CR54","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1212\/WNL.51.2.526","volume":"51","author":"C Cornella","year":"1998","unstructured":"Cornella C, Nadrdine T, Diederich N, Stebbins G. Sleep-related violence, injury and REM sleep behavior disorder in Parkinsons\u2019s disease. Neurology. 1998;51:526\u20139.","journal-title":"Neurology"},{"key":"508_CR55","doi-asserted-by":"crossref","unstructured":"McCarter S, St Louis E, Boswell C, Dueffert L, Slocumb N, Boeve B, et al. Factors associated with injury in REM sleep behavior disorder. Sleep Med. 2014;15(11):1332\u20138.","DOI":"10.1016\/j.sleep.2014.06.002"},{"issue":"Pt 2","key":"508_CR56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/brain\/123.2.331","volume":"123","author":"E Olson","year":"2000","unstructured":"Olson E, Boeve B, Silber M. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123(Pt 2):331\u20139.","journal-title":"Brain"},{"key":"508_CR57","doi-asserted-by":"crossref","unstructured":"Aurora R, Zak R, Maganti R, Auerbach S, Casey K, Chowdhuri S, et al. Standards of Practice Committee and American Academy of Sleep Medicine, Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6(1):85\u201395.","DOI":"10.5664\/jcsm.27717"},{"key":"508_CR58","doi-asserted-by":"crossref","unstructured":"Frauscher B, Jennum P, Ju Y, Postuma R, Arnulf I, Cochen De Cock V, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014;82(12):1076\u20139.","DOI":"10.1212\/WNL.0000000000000247"},{"key":"508_CR59","doi-asserted-by":"crossref","unstructured":"Postuma R, Gagnon J, Tuineaig M, Bertrand J, Latreille V, Desjardins C, et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36(11):1579\u201385.","DOI":"10.5665\/sleep.3102"},{"key":"508_CR60","doi-asserted-by":"crossref","first-page":"529","DOI":"10.5664\/jcsm.26919","volume":"3","author":"J Parish","year":"2007","unstructured":"Parish J. Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was ghting Saddam Hussein. J Clin Sleep Med. 2007;3:529\u201331.","journal-title":"J Clin Sleep Med"},{"key":"508_CR61","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/sleep\/15.3.226","volume":"15","author":"C Schenck","year":"1992","unstructured":"Schenck C, Mahowald M, Kim S, O\u2019Connor K, Hurwitz T. Prominent eye movements during nrem sleep and rem sleep behavior disorder associated with uoxetine treatment of depression and obsessive-compulsive disorder. Sleep. 1992;15:226\u201335.","journal-title":"Sleep"},{"key":"508_CR62","first-page":"25","volume":"364","author":"S Schutte","year":"1996","unstructured":"Schutte S, Doghramji K. REM behavior disorder seen with venlafaxine (efexor). Sleep Res. 1996;364:25.","journal-title":"Sleep Res"},{"key":"508_CR63","first-page":"61","volume":"1161","author":"M Onofrj","year":"2003","unstructured":"Onofrj M, Thomas A, Nash J, Wilson S, Potokar J, Nutt D. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism\u2014correspondence. Neurology. 2003;1161:61.","journal-title":"Neurology"},{"key":"508_CR64","doi-asserted-by":"crossref","unstructured":"Tan L, Zhou J, Liang B, Li Y, Lei F, Du L, et al. A case of quetiapine-induced rapide eye movement sleep behavior disorder. Biol Psychiatry. 2016;79(5):e11\u20132.","DOI":"10.1016\/j.biopsych.2014.08.002"},{"key":"508_CR65","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0002-9343(99)00245-4","volume":"107","author":"A Iranzo","year":"1999","unstructured":"Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med. 1999;107:390\u20132.","journal-title":"Am J Med"},{"key":"508_CR66","first-page":"25","volume":"371","author":"M Silber","year":"1996","unstructured":"Silber M. REM sleep behavior disorder associated with barbiturate withdrawal. Sleep Res. 1996;371:25.","journal-title":"Sleep Res"},{"issue":"Suppl 2","key":"508_CR67","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.sleep.2011.10.011","volume":"12","author":"R Manni","year":"2011","unstructured":"Manni R, Ratti P, Terzaghi M. Secondary \u201cincidental\u201d REM sleep behavior disorder: do we ever think of it? Sleep Med. 2011;12(Suppl 2):S50\u20133.","journal-title":"Sleep Med"},{"key":"508_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/sleep\/23.4.1e","volume":"23","author":"H Chiu","year":"2000","unstructured":"Chiu H, Wing Y, Lam L. Sleep-related injury in the elderly\u2014an epidemiological study in Hong Kong. Sleep. 2000;23:1\u20135.","journal-title":"Sleep"},{"key":"508_CR69","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1136\/jnnp.2008.155374","volume":"79","author":"Y Wing","year":"2008","unstructured":"Wing Y, Lam S, Li S. REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry. 2008;79:1415\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl","key":"508_CR70","first-page":"S9","volume":"57","author":"C Schenck","year":"1990","unstructured":"Schenck C, Mahowald M. A polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Clev Clin J Med. 1990;57(Suppl):S9\u2013S23.","journal-title":"Clev Clin J Med"},{"key":"508_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/B0-72-160797-7\/50082-3","volume-title":"Rem Sleep Parasomnias","author":"M Mahowald","year":"2005","unstructured":"Mahowald M, Schenck C. Principles and practice of sleep medicine, 4th ed. In: Rem Sleep Parasomnias. Philadelphia: Elsevier Saunders; 2005."},{"key":"508_CR72","first-page":"4","volume":"157\u201363","author":"V Abad","year":"2004","unstructured":"Abad V, Guilleminault C. Review of rapid eye movement behavior sleep disorders. Review of rapid eye movement behavior sleep disorders. 2004;157\u201363:4.","journal-title":"Review of rapid eye movement behavior sleep disorders"},{"key":"508_CR73","doi-asserted-by":"crossref","unstructured":"Raskind M, Peterson K, Williams T, Hoff D, Hart K, Holmes H, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-dury soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170:1003\u201310.","DOI":"10.1176\/appi.ajp.2013.12081133"},{"issue":"2","key":"508_CR74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","volume":"9","author":"C Schenck","year":"1986","unstructured":"Schenck C, Bundlie S, Ettinger M, Mahowald M. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293\u2013308.","journal-title":"Sleep"},{"key":"508_CR75","doi-asserted-by":"crossref","unstructured":"Li S, Lam S, Zhang J, Yu M, Chan J, Liu Y, et al. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med. 2016;21:114\u201320. Thirty-nine iRBD patients (mean age at diagnosis: 68.3\u2009\u00b1\u20097.8 years) were studied with a follow-up duration of 28.8\u2009\u00b1\u200913.3 months. Clonazepam treatment proved to differentially change dream effect and content and to reduce verbal and motor behaviors. However, residual RBD symptoms persisted.","DOI":"10.1016\/j.sleep.2015.12.020"},{"key":"508_CR76","doi-asserted-by":"crossref","unstructured":"McCarter S, Boswell C, St Louis E, Dueffert L, Slocumb N, Boeve B, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;14(3):237\u201342.","DOI":"10.1016\/j.sleep.2012.09.018"},{"issue":"4","key":"508_CR77","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejim.2014.02.008","volume":"25","author":"M Terzaghi","year":"2014","unstructured":"Terzaghi M, Sartori I, Rustioni V, Manni R. Sleep disorders and acute nocturnal delirium in the elderly: a comorbidity not to be overlooked. Eur J Intern Med. 2014;25(4):350\u20135.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"508_CR78","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1212\/WNL.42.7.1371","volume":"42","author":"O Lapierre","year":"1992","unstructured":"Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology. 1992;42(7):1371\u20134.","journal-title":"Neurology"},{"key":"508_CR79","doi-asserted-by":"crossref","unstructured":"Ferri R, Rundo F, Silvani A, Zucconi M, Bruni O, Ferini-Strambi L, et al. REM sleep EEG instability in REM sleep behavior disorder and clonazepam effects. Sleep. 2017;40(8):1.","DOI":"10.1093\/sleep\/zsx080"},{"key":"508_CR80","doi-asserted-by":"crossref","unstructured":"Ferri R, Marelli S, Ferini-Strambi L, Oldani A, Colli F, Schenck CH, et al. An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder. Sleep Medicine. 2013;14(1):24\u20139.","DOI":"10.1016\/j.sleep.2012.09.009"},{"issue":"4","key":"508_CR81","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","volume":"19","author":"D Kunz","year":"2010","unstructured":"Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behavior disorder. J Sleep Res. 2010;19(4):591\u20136.","journal-title":"J Sleep Res"},{"key":"508_CR82","doi-asserted-by":"crossref","unstructured":"Xie Z, Chen F, Li W, Geng X, Li C, Meng X, et al. A review of sleep disorders and melatonin. Neurol Res. 2017;39(6):559\u201365.","DOI":"10.1080\/01616412.2017.1315864"},{"key":"508_CR83","first-page":"4","volume":"281\u20134","author":"B Boeve","year":"2003","unstructured":"Boeve B, Silber M, Ferman T. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;281\u20134:4.","journal-title":"Sleep Med"},{"issue":"3","key":"508_CR84","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8","volume":"14","author":"D Kunz","year":"1999","unstructured":"Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labaled pilot study on the possible influencec of melatonin on REM-sleep regulation. Mov Disord. 1999;14(3):507\u201311.","journal-title":"Mov Disord"},{"issue":"18","key":"508_CR85","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2169\/internalmedicine.52.9179","volume":"52","author":"T Nomura","year":"2013","unstructured":"Nomura T, Kawase S, Watanabe Y, Nakashima K. Use of ramelteon for the treatment of secondary REM sleep behavior disorder. Intern Med. 2013;52(18):2123\u20136.","journal-title":"Intern Med"},{"key":"508_CR86","doi-asserted-by":"crossref","unstructured":"Esaki Y, Kitajima T, Koike S, Fujshiro H, Iwata Y, Tsuchiya A, et al. An open-labeled trial of ramelteon in idiopathic rapid eye movement sleep Behavior Disorder. Clin Sleep Med. 2016;12(5):689\u201393.","DOI":"10.5664\/jcsm.5796"},{"issue":"5","key":"508_CR87","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/JCP.0b013e31826866f8","volume":"32","author":"A Bonakis","year":"2012","unstructured":"Bonakis A, Economou N, Papageorgiou S, Vagiakis E, Nanas S, Paparrigopoulos T. Agomelatine may improve REM sleep behavior disorder symptoms. J Clin Psychipharmacol. 2012;32(5):732\u20134.","journal-title":"J Clin Psychipharmacol"},{"issue":"10","key":"508_CR88","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/WNL.61.10.1418","volume":"61","author":"M Fantini","year":"2003","unstructured":"Fantini M, Cagnon J, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology. 2003;61(10):1418\u201320.","journal-title":"Neurology"},{"issue":"5","key":"508_CR89","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.sleep.2006.03.018","volume":"7","author":"M Schmidt","year":"2006","unstructured":"Schmidt M, Koshal V, Schmidt H. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med. 2006;7(5):418\u201323.","journal-title":"Sleep Med"},{"key":"508_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.parkreldis.2012.08.010","volume":"19","author":"T Sasai","year":"2013","unstructured":"Sasai T, Matsuura M, Ionue Y. Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism and Related Disorders. 2013;19:153\u20137.","journal-title":"Parkinsonism and Related Disorders"},{"issue":"9","key":"508_CR91","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/sleep\/20.9.757","volume":"20","author":"D Rye","year":"1997","unstructured":"Rye D. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep. 1997;20(9):757\u201388.","journal-title":"Sleep"},{"issue":"6","key":"508_CR92","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/WNL.55.6.870","volume":"55","author":"J Ringman","year":"2000","unstructured":"Ringman J, Simmons J. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology. 2000;55(6):870\u20131.","journal-title":"Neurology"},{"issue":"4","key":"508_CR93","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mds.24909","volume":"27","author":"R Giacopo Di","year":"2012","unstructured":"Di Giacopo R, Fasano A, Quaranta D, Della Marca G, Bove F, Bentivoglio A, et al. Mov Disord. 2012;27(4):559\u201361.","journal-title":"Mov Disord"},{"key":"508_CR94","doi-asserted-by":"crossref","unstructured":"Brunetti V, Losurdo A, Testani E, Lapenta L, Mariotti P, Marra C, et al. Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. Curr Alzheimer Res. 2014;11(3):267\u201373.","DOI":"10.2174\/1567205011666140302195648"},{"issue":"4","key":"508_CR95","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1017\/S1041610203009621","volume":"15","author":"G Massironi","year":"2003","unstructured":"Massironi G, Galluzzi S, Frisoni G. Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies. Int Psychogeriatr. 2003;15(4):377\u201383.","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"508_CR96","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1389-9457(03)00072-8","volume":"4","author":"B Boeve","year":"2003","unstructured":"Boeve B, Silber M, Ferman T. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281\u20134.","journal-title":"Sleep Med"},{"issue":"2","key":"508_CR97","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5664\/jcsm.27771","volume":"6","author":"S Yeh","year":"2010","unstructured":"Yeh S, Yeh P, Schenck C. Rivastigmine.induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer\u2019s disease. J Clin Sleep Med. 2010;6(2):192\u20135.","journal-title":"J Clin Sleep Med"},{"key":"508_CR98","doi-asserted-by":"crossref","unstructured":"Terzaghi M, Arnaldi D, Rizzetti M, Minafra B, Cremascoli R, Rustioni V, et al. Analysis of video-polysomnographic sleep findings in dementia with Lewy Bodies. Mov Disord. 2013;28(10):1416\u201323.","DOI":"10.1002\/mds.25523"},{"issue":"4","key":"508_CR99","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","volume":"19","author":"K Babson","year":"2017","unstructured":"Babson K, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19(4):23.","journal-title":"Curr Psychiatry Rep"},{"key":"508_CR100","doi-asserted-by":"crossref","unstructured":"Chagas M, Eckeli A, Zuardi A, Pena-Pereira M, Sobreira-Neto M, Sobreira E, et al. Cannabidiol can improve complex sleep-related behaviors associated with rapid eye movement sleep behavior disorder in Parkinson\u2019s disease patients: a case series. J Clin Pharm Ther. 2014;39(5):564\u20136.","DOI":"10.1111\/jcpt.12179"},{"key":"508_CR101","first-page":"110","volume":"518\u201320","author":"A Bonakis","year":"2008","unstructured":"Bonakis A, Howard R, Williams A. Narcolepsy presenting as REM sleep behaviour disorder. Clin Neurol Neurosurg. 2008;518\u201320:110.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"508_CR102","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.27492","volume":"5","author":"K Anderson","year":"2009","unstructured":"Anderson K, Shneerson J. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med. 2009;5(3):235\u20139.","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"508_CR103","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11940-016-0433-2","volume":"18","author":"Y Jung","year":"2016","unstructured":"Jung Y, St Louis E. Treatment of REM sleep behavior disorder. Curr Treat Options. 2016;18(11):50. This is a comprehensive review of therapeutic options in RBD. Melatonin 3\u201312\u00a0mg and clonazepam 0.25\u20132\u00a0mg with most advisable dosages of 6 and 0.5\u00a0mg respectively are considered as first-line treatment. Alternative second- and third-line therapies with anecdotal efficacy of temazepam, lorazepam, zolpidem, zopiclone, pramipexole, donepezil, ramelteon, agomelatine, cannabinoids, and sodium oxybate are reported. Non-pharmacological options are also considered.","journal-title":"Curr Treat Options"},{"key":"508_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.sleep.2016.04.014","volume":"31","author":"K Moghadam","year":"2017","unstructured":"Moghadam K, Pizza F, Primavera A, Ferri R, Plazzi G. Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients. Sleep Med. 2017;31:16\u201321.","journal-title":"Sleep Med"},{"issue":"3","key":"508_CR105","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/WNF.0b013e318193e394","volume":"32","author":"J Shneerson","year":"2009","unstructured":"Shneerson J. Successful treatment of REM sleep behavior disorder with sodium oxybate. Clin Neuropharmacol. 2009;32(3):158\u20139.","journal-title":"Clin Neuropharmacol"},{"key":"508_CR106","doi-asserted-by":"crossref","unstructured":"Aurora R, Zak R, Auerbach S, Casey K, Chowdhueri S, Karippot A, et al. Best practice guide for the treatment of nightmare disorder in adults. J Clin Sleep Med. 2010;6(4):389\u2013401.","DOI":"10.5664\/jcsm.27883"},{"key":"508_CR107","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.mayocp.2012.05.015","volume":"87","author":"S Kung","year":"2012","unstructured":"Kung S, Espinel Z, Lapid M. Treatment of nightmares with prazosin: a systematic review. Mayo Clin Proc. 2012;87:890\u2013900.","journal-title":"Mayo Clin Proc"},{"key":"508_CR108","doi-asserted-by":"crossref","unstructured":"George K, Kebejian L, Ruth L, Miller C, Himelhoch S. tsaMeta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation. 2016;17(4):494\u2013510. The meta-analysis document the efficacy of prazosin in treating PTSD-related nightmares. Prazosin proved to be well tolerated and not to induce arterial hypertension, when carefully titrated.","DOI":"10.1080\/15299732.2016.1141150"},{"key":"508_CR109","doi-asserted-by":"crossref","unstructured":"Hudson S, Whiteside T, Lorenz R, Wargo K. Prazosin for hte treatment of nightmares related to posttraumatic stess disorder: a review of the literature. The primary Care Companion to CNS disorders. 2012;14(2)","DOI":"10.4088\/PCC.11r01222"},{"issue":"10","key":"508_CR110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11920-017-0827-1","volume":"19","author":"K Miller","year":"2017","unstructured":"Miller K, Brownlow J, Woodward S, Gehrman P. Sleep and dreaming in posttraumatic Stress disorder. Curr Psychiatry Rep. 2017;19(10):71.","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"508_CR111","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1819.2003.01207.x","volume":"58","author":"S Miyazaki","year":"2004","unstructured":"Miyazaki S, Uchida S, Mukai J, Nishihara K. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin Neurosci. 2004;58(2):138\u201344.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"9","key":"508_CR112","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/00005053-198909000-00005","volume":"177","author":"J Kinzie","year":"1989","unstructured":"Kinzie J, Leung P. Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis. 1989;177(9):546\u201350.","journal-title":"J Nerv Ment Dis"},{"issue":"10","key":"508_CR113","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00005053-199410000-00010","volume":"182","author":"J Kinzie","year":"1994","unstructured":"Kinzie J, Sack R, Riley C. The polysomnographic effects of clonidine on sleep disorders in posttraumatic stress disorder: a pilot study with Cambodian patients. J Nerv Ment Dis. 1994;182(10):585\u20137.","journal-title":"J Nerv Ment Dis"},{"issue":"8","key":"508_CR114","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","volume":"34","author":"P Roitman","year":"2014","unstructured":"Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral \u03949-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig. 2014;34(8):587\u201391. Ten patients with chronic PTSD received \u03949-tetrahydrocannabinol 5\u00a0mg bid as add-on treatment, with significant improvement in global symptom severity, sleep quality, and frequency of nightmares.","journal-title":"Clin Drug Investig"},{"key":"508_CR115","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","volume":"51","author":"R Jetly","year":"2015","unstructured":"Jetly R, Heber A, Fraser G, Boisvert D. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology. 2015;51:585\u20138.","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"508_CR116","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","volume":"34","author":"C Cameron","year":"2014","unstructured":"Cameron C, Watson D, Robinson J. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation. J Clin Psychopharmacol. 2014;34(5):559\u201364.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"508_CR117","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1682\/JRRD.2011.09.0183","volume":"49","author":"M Jeffreys","year":"2012","unstructured":"Jeffreys M, Capehart B, Friedman M. Pharmacotherapy for posttraumatic stress disorder: review with clinical application. J Rehabil Res Dev. 2012;49(6):703\u201315.","journal-title":"J Rehabil Res Dev"},{"issue":"12","key":"508_CR118","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/jcm5120117","volume":"5","author":"M Detweiler","year":"2016","unstructured":"Detweiler M, Pagadala B, Candelario J, Boyle J, Detweiler J, Lutgens B. Treatment of post-traumatic stress disorder nightmares at a Veterans Affairs Medical Center. J Clin Med. 2016;5(12):117.","journal-title":"J Clin Med"},{"issue":"1","key":"508_CR119","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10072-011-0644-y","volume":"33","author":"M Terzaghi","year":"2012","unstructured":"Terzaghi M, Ratti P, Manni F, Manni R. Sleep paralysis in narcolepsy: more than just a motor dissociative phenomenon? Neurol Sci. 2012;33(1):169\u201372.","journal-title":"Neurol Sci"},{"issue":"5","key":"508_CR120","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0022-510X(66)90001-3","volume":"3","author":"Y Hishikawa","year":"1966","unstructured":"Hishikawa Y, Ida H, Nakai K, Kaneko Z. Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran). Neurol Sci. 1966;3(5):453\u201361.","journal-title":"Neurol Sci"},{"issue":"1","key":"508_CR121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1600-0404.1976.tb07621.x","volume":"54","author":"C Guilleminault","year":"1976","unstructured":"Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand. 1976;54(1):71\u201387.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"508_CR122","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00004691-199001000-00008","volume":"7","author":"M Mitler","year":"1990","unstructured":"Mitler M, Hajdukovic R, Erman M, Koziol K. Narcolepsy. J Clin Neurophysion. 1990;7(1):93\u2013118.","journal-title":"J Clin Neurophysion"},{"issue":"2","key":"508_CR123","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0033-3182(93)71913-1","volume":"34","author":"L Koran","year":"1993","unstructured":"Koran L, Rahavan S. Fluoxetine for isolated sleep paralysis. Psychosomatics. 1993;34(2):184\u20137.","journal-title":"Psychosomatics"},{"issue":"4","key":"508_CR124","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1600-0404.1986.tb03518.x","volume":"74","author":"H Schrader","year":"1986","unstructured":"Schrader H, Kayed K, Bendixen Markset A, Treidene H. The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo. Acta Neurol Scand. 1986;74(4):297\u2013303.","journal-title":"Acta Neurol Scand"},{"key":"508_CR125","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/NSS.S103467","volume":"9","author":"V Abad","year":"2017","unstructured":"Abad V, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep. 2017;9:39\u201357.","journal-title":"Nat Sci Sleep"},{"issue":"10","key":"508_CR126","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0333102414536059","volume":"34","author":"A Frese","year":"2014","unstructured":"Frese A, Summ O, Evers S. Exploding head syndrome: six new cases and review of the literature. Cephalalgia. 2014;34(10):823\u20137.","journal-title":"Cephalalgia"},{"issue":"3","key":"508_CR127","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/sleep\/14.3.263","volume":"14","author":"C Sachs","year":"1991","unstructured":"Sachs C, Svanborg E. The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep. 1991;14(3):263\u20136.","journal-title":"Sleep"},{"issue":"4","key":"508_CR128","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1468-2982.2007.01522.x","volume":"28","author":"A Chakravarty","year":"2008","unstructured":"Chakravarty A. Exploding head syndrome: report of two new cases. Cephalalgia. 2008;28(4):399\u2013400.","journal-title":"Cephalalgia"},{"issue":"5","key":"508_CR129","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1046\/j.1468-2982.2001.00227.x","volume":"21","author":"D Jacome","year":"2001","unstructured":"Jacome D. Exploding head syndrome and idiopathic stabbing headache relieved by nifedipine. Cephalalgia. 2001;21(5):617\u20138.","journal-title":"Cephalalgia"},{"issue":"4","key":"508_CR130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5664\/jcsm.27881","volume":"6","author":"G Palikh","year":"2010","unstructured":"Palikh G, Vaughn B. Topiramate responsive exploding head syndrome. J Clin Sleep Med. 2010;6(4):382\u20133.","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"508_CR131","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.smrv.2014.03.001","volume":"18","author":"B Sharpless","year":"2014","unstructured":"Sharpless B. Exploding head syndrome. Sleep Med Rev. 2014;18(6):489\u201393.","journal-title":"Sleep Med Rev"},{"issue":"4","key":"508_CR132","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1440-1754.2012.02506.x","volume":"49","author":"M Harari","year":"2013","unstructured":"Harari M. Nocturnal enuresis. J Paediatr Child Health. 2013;49(4):264\u201371.","journal-title":"J Paediatr Child Health"},{"key":"508_CR133","doi-asserted-by":"crossref","unstructured":"Caldwell P, Nankivell G, Sureshkumar P. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2013;(7):CD003637.","DOI":"10.1002\/14651858.CD003637.pub3"},{"issue":"1","key":"508_CR134","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1179\/2046905515Y.0000000023","volume":"36","author":"S Jain","year":"2016","unstructured":"Jain S, Bhatt G. Advances in the management of primary monosymptomatic nocturnal enuresis in children. Paediatr Int Child Health. 2016;36(1):7\u201314.","journal-title":"Paediatr Int Child Health"},{"key":"508_CR135","doi-asserted-by":"crossref","unstructured":"Kuwertz-Br\u00f6king E, von Gontard A. Clinical management of nocturnal enuresis. Paediatr Nephrol. 2017;","DOI":"10.1007\/s00467-017-3778-1"},{"key":"508_CR136","doi-asserted-by":"crossref","unstructured":"Glazener C, Evans J, Cheuk D. Complementary and miscellaneous interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2005;(2):CD005230.","DOI":"10.1002\/14651858.CD005230"},{"key":"508_CR137","doi-asserted-by":"crossref","unstructured":"Neveus T, Eggert P, Evans J, Macedo A, Rittig S, Tekg\u00fcl S, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children\u2019s Continence Society. J Urol. 2010;183(2):441\u20137.","DOI":"10.1016\/j.juro.2009.10.043"},{"issue":"8","key":"508_CR138","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00467-011-1762-8","volume":"26","author":"T Nev\u00e9us","year":"2011","unstructured":"Nev\u00e9us T. Nocturnal enuresis-theoretic background and practical guidelines. Pediatr Nephrol. 2011;26(8):1207\u201314.","journal-title":"Pediatr Nephrol"},{"key":"508_CR139","first-page":"155","volume":"432\u2013434","author":"P Gish","year":"2009","unstructured":"Gish P, Mosholder A, Truffa M, Johann-Liang R. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. J Pediatr. 2009;432\u2013434:155.","journal-title":"J Pediatr"},{"key":"508_CR140","unstructured":"4th International Consultation on Incontinence, 2009."},{"key":"508_CR141","doi-asserted-by":"crossref","unstructured":"Yu J, Yan Z, Zhou S, Han F, Xiao F, Han J, et al. Desmopressin plus anticholinergic agent in the treatment of nocturnal enuresis: a meta-analysis. Exp Ther Med. 2017;14(4):2875\u201384. The efficacy and safety of the therapy combining desmopressin and anticholinergics compared with desmopressin monotherapy in treating nocturnal enuresis is stressed.","DOI":"10.3892\/etm.2017.4897"},{"key":"508_CR142","first-page":"CD002238","volume":"12","author":"A Deshpande","year":"2012","unstructured":"Deshpande A, Caldwell P, Sureshkumar P. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database Syst Rev. 2012;12:CD002238.","journal-title":"Cochrane Database Syst Rev"},{"key":"508_CR143","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/cap.2000.10.321","volume":"10","author":"C Varley","year":"2000","unstructured":"Varley C. Sudden death of a child treated with imipramine. Case study. J Child Adolesc Psychopharmachol. 2000;10:321\u20135.","journal-title":"J Child Adolesc Psychopharmachol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-018-0508-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-018-0508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T23:58:38Z","timestamp":1693699118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-018-0508-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":143,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1007\/s11940-018-0508-3","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"5 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"26"}}